EXCELINDUS - Excel Industries Limited
NSE
->
Basic Materials
->
Specialty Chemicals
Mumbai,
India
Type: Equity
EXCELINDUS price evolution
EXCELINDUS
| (in millions $) | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 | 29 Sep 2021 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $303.08 | $484.92 | ||
| Short term investments | $348.26 | $153.73 | ||
| Net receivables | $2052.24 | $1574.15 | ||
| Inventory | $1652.26 | $1018.4 | ||
| Total current assets | $4784.76 | $3417.05 | ||
| Long term investments | $5346.59 | $5446.48 | ||
| Property, plant & equipment | $4280.6 | $4191.89 | ||
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14866.46 | $13512.46 | ||
| Current liabilities | ||||
| Accounts payable | $1804.48 | $1290.69 | ||
| Deferred revenue | ||||
| Short long term debt | $0.06 | $92.25 | ||
| Total current liabilities | $2024.59 | $1778.89 | ||
| Long term debt | ||||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $3372.97 | $3133.72 | ||
| Shareholders' equity | ||||
| Retained earnings | $7265.99 | |||
| Other shareholder equity | $4111.21 | $10315.88 | ||
| Total shareholder equity | $11493.49 | $11493.49 | $10378.74 | $10378.74 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $303.08 | $423.49 | $209.24 | $35.89 |
| Short term investments | $348.26 | $66.33 | $3.15 | $11.93 |
| Net receivables | $2052.24 | $1789.78 | $1562.66 | $1680.81 |
| Inventory | $1652.26 | $689.71 | $777.2 | $687.47 |
| Total current assets | $4784.76 | $3291.94 | $2802.13 | $3267.29 |
| Long term investments | $5346.59 | $3497.05 | $2496.07 | $3170.43 |
| Property, plant & equipment | $4280.6 | $3856.85 | $3649.16 | $2482.58 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $14866.46 | $11111.49 | $9373.46 | $9156.97 |
| Current liabilities | ||||
| Accounts payable | $1804.48 | $1230.06 | $1049.08 | $998.17 |
| Deferred revenue | ||||
| Short long term debt | $0.06 | $0.16 | $0.41 | $1.63 |
| Total current liabilities | $2024.59 | $1574.2 | $1481.08 | $1168.91 |
| Long term debt | $0.06 | $0.21 | $0.63 | |
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $3372.97 | $2596.09 | $2364.56 | $2161.33 |
| Shareholders' equity | ||||
| Retained earnings | $7265.99 | $5792.45 | $5088.62 | $4580.4 |
| Other shareholder equity | $4111.21 | $2606.67 | $1803.99 | $2298.95 |
| Total shareholder equity | $11493.49 | $8515.41 | $7008.9 | $6995.64 |
| (in millions $) | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 | 29 Sep 2021 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $3288.15 | $3646.65 | $3505.24 | $2309.2 |
| Cost of revenue | $1820.88 | $2331.6 | $1538.54 | $1241.33 |
| Gross Profit | $1467.27 | $1315.06 | $1966.69 | $1067.87 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $268.39 | $333.64 | $295.25 | $243.35 |
| Total operating expenses | $2814.06 | $3042.9 | $2560.27 | $2100.03 |
| Operating income | $474.09 | $603.75 | $944.97 | $209.18 |
| Income from continuing operations | ||||
| EBIT | $474.09 | $603.75 | $944.97 | $209.18 |
| Income tax expense | $124.64 | $150.24 | $243.43 | $55.89 |
| Interest expense | -$5 | -$0.01 | -$4.3 | -$4.67 |
| Net income | ||||
| Net income | $370.46 | $447.87 | $778.5 | $171.4 |
| Income (for common shares) | $370.46 | $447.87 | $778.5 | $171.4 |
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $11780.2 | $7494.66 | $7024.84 | $8252.45 |
| Cost of revenue | $6380.94 | $3909.14 | $3505.33 | $3732.69 |
| Gross Profit | $5399.26 | $3585.51 | $3519.51 | $4519.76 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $1107.54 | $937.18 | $875.62 | $793.84 |
| Total operating expenses | $9769.16 | $6533.61 | $5947.33 | $5913.26 |
| Operating income | $2011.04 | $961.05 | $1077.52 | $2339.2 |
| Income from continuing operations | ||||
| EBIT | $2011.04 | $961.05 | $1077.52 | $2339.2 |
| Income tax expense | $522.51 | $297.24 | $188.33 | $807.54 |
| Interest expense | -$15 | -$17.75 | -$22.25 | -$19.59 |
| Net income | ||||
| Net income | $1612.03 | $710.86 | $960.73 | $1534.54 |
| Income (for common shares) | $1612.03 | $710.86 | $960.73 | $1534.54 |
| (in millions $) | 29 Jun 2022 | 30 Mar 2022 | 30 Dec 2021 | 29 Sep 2021 |
|---|---|---|---|---|
| Net income | $370.46 | $447.87 | $778.5 | $171.4 |
| Operating activities | ||||
| Depreciation | ||||
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | ||||
| Investing activities | ||||
| Capital expenditures | ||||
| Investments | ||||
| Total cash flows from investing | ||||
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | ||||
| Net borrowings | ||||
| Total cash flows from financing | ||||
| Effect of exchange rate | ||||
| Change in cash and equivalents | ||||
| (in millions $) | 30 Mar 2022 | 30 Mar 2021 | 30 Mar 2020 | 30 Mar 2019 |
|---|---|---|---|---|
| Net income | $1612.03 | $710.86 | $960.73 | $1534.54 |
| Operating activities | ||||
| Depreciation | $304.73 | $269.1 | $224.97 | $175.5 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | $1089.34 | $908.56 | $1101.78 | $1351.55 |
| Investing activities | ||||
| Capital expenditures | -$737.07 | -$476.95 | -$652.33 | -$462.07 |
| Investments | -$341.34 | -$52.22 | $600.57 | -$684.55 |
| Total cash flows from investing | -$1040.86 | -$525.98 | -$613.84 | -$1112.14 |
| Financing activities | ||||
| Dividends paid | -$141.57 | -$141.57 | -$361.41 | -$157.13 |
| Sale and purchase of stock | ||||
| Net borrowings | -$14.02 | -$157.45 | $140.2 | -$30.08 |
| Total cash flows from financing | -$168.89 | -$168.34 | -$314.59 | -$243.86 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$120.41 | $214.25 | $173.34 | -$4.46 |
News
Fundamentals
| Market cap | N/A |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | N/A |
| Revenue | $12.75B |
|---|---|
| EBITDA | N/A |
| EBIT | $2.23B |
| Net Income | $1.77B |
| Revenue Q/Q | 41.79% |
| Revenue Y/Y | 50.36% |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | 16.17% |
| Debt/Equity | 0.29 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | N/A |
| Quick ratio | N/A |